Good post Chips.... I think its important to be realistic about these things so I hope people reading this forum will pay attention to what you said. It is all about quantity and quality of centres ordering at this stage, not the number of patches sold so lets focus on that and of course if the company gets THAT right then the number of patches sold will follow. Although I will predict this.... Admedus is just about to set off on the path of numerous other great Australian healthcare success stories which report quarter after quarter of increased revenues. The market worships companies like this so I am expecting a serious rerating over the next year.
16 Centres Ordering in Europe, page-18
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |